A clear threshold effect was observed: Patients above ~5.97 ng/mL endoxifen had a ~30% lower risk of recurrence Patients below this threshold represented a higher-risk group Importantly, ~20% of patients fell below this level under standard dosing conditions
Patients with genetic variants associated with slower adipose tissue absorption may benefit from specific injection site selectionfor example, the abdomen often provides faster systemic absorption than the thigh
For patients who plateau early or respond less than expected, the Precision Peptide test can inform whether dose escalation, medication switching, or combination therapy (such as PlexusDx GLP-Squared, which combines semaglutide and tirzepatide) is most likely to work
Higher doses dont have any clinical basis and may increase risk
DHT levels return to baseline within months, and the hair you were holding onto resumes thinning
Type: Prescription Medicine Solution for Injection